| Copper ions modulate prion protein phase transitions |
|
2023 |
| Phase separation research applied to the study of the biological function of the prion protein |
|
2023 |
| MUTANT p53 AMYLOID AGGREGATES TRANSMISSION THROUGH EXTRACELLULAR VESICLES IN BREAST CANCER |
|
2023 |
| Phase separation research applied to the study of the biological function of prion protein |
|
2022 |
| Modulation of Alpha-Synuclein Aggregation by Organic Compounds |
|
2022 |
| A high-affinity DNA hairpin binds to the prion protein globular domain leading to partial unfolding and liquid phase separation |
|
2019 |
| New method for prion protein aggregation in vitro as a useful tool to select and study therapeutic compounds against prion diseases |
|
2019 |
| Brain expressed x-linked (BEX3) and its transitions from intrinsic disorder to the formation of ordered 3D fold and liquid-liquid phase separation |
|
2019 |
| Evaluation of recombinant prion protein interaction with Cu(II) and nucleic acids: insights into the pathophysiology of prion disorders |
|
2019 |
| Changes in phase transition in p53 induced by solvation and high pressure |
|
2019 |
| Liquid liquid phase separation and aggregation of the prion protein modulated by a high affinity DNA aptamer |
|
2019 |
| Heparin Binding Confers Prion Stability And Impairs Its Aggregation |
|
2014 |
| Identification Of Promising Anti-Prion Drug Candidates Through Ex-Vivo, In Vitro And In Silico Methodologies |
|
2014 |
| In Silico Evaluation of Pharmacodynamic and Pharmacokinetic Parameters and In Vitro Mutagenicity Analysis of Anti-Prion Compounds |
|
2014 |
| Intramolecular Dynamics Within the N-Cap-SH3-SH2 Regulatory Unit of the c-Abl Tyrosine Kinase Reveal Targeting to the Cellular Membrane |
|
2014 |
| Pathological Implications of Nucleic Acids Interactions With Prion Proteins: In Vitro and In Vivo Approaches |
|
2014 |
| CROSS-TALK BETWEEN PRION PROTEIN AND NUCLEIC ACIDS: PROTEIN MISFOLDING LEADING TO CYTOTOXICITY |
|
2013 |
| CONFORMATIONAL ENSEMBLES OF GLYCOSYLATED PRION PROTEIN: A STRATEGY FOR MAPPING INTERACTIONS WITH PHYSIOLOGICAL AND THERAPEUTIC LIGANDS |
|
2013 |
| ISOLATION AND CHARACTERIZATION OF RNA MOLECULES BOUND TO RECOMBINANT MOUSE PRION PROTEIN |
|
2013 |
| RABBITS AND THEIR RESISTANCE TO PRION INFECTION: A MATTER OF ALTERED PRP-NUCLEIC ACID INTERACTIONS? |
|
2013 |
| Parkinson's disease: evaluating the effects of possible anti-parkinsonian compounds on alpha-synuclein aggregation and neurotoxicity |
|
2012 |
| HEPARIN BINDING INCREASES MURINE PRION PROTEIN STABILITY |
|
2012 |
| Modulation of a Prion Peptide aggregation by Chalcones: Therapeutic Implication |
|
2012 |
| Non-Specific Prion Protein?Nucleic Acid Interactions Lead into Different Aggregates and Cytotoxic Species |
|
2012 |
| Commercial Enzymes in Reverse Micelles Nanosystems: Structure-Activity Relationship |
|
2012 |
| Time-Dependent Conformation Profile of c-Abl Protein Reveals New Insights on Its Regulation and Functionality |
|
2012 |
| Moniliophtora perniciosa Necrosis- and Ethylene-Inducing Protein 2 (MpNep2) as a Dimer in Solution: Structural and Functional Implications |
|
2012 |
| Allosteric Effect of Ligands in Prion Protein Studied through Teorical and Experimental Methods for Structural Prediction |
|
2012 |
| New Aminoquinoline Compounds Inhibit Aggregation of the Syrian Hamster Prion Peptide and are Potential Lead Compounds Against Prion Diseases |
|
2010 |
| MpNep2 from Moniliophthora perniciosa Recover Necrosis Activity after Exposure to Temperature |
|
2010 |
| Evaluation of the Effect of Copper in the Aggregation and Conformation |
|
2010 |
| Insights on PrP Interaction with RNA Molecules |
|
2010 |
| Prion Protein Interaction with Low Molecular Weight Heparin |
|
2010 |
| Structural and physiological implications of prion protein interaction with DNA |
|
2009 |
| Prion protein aggregation and toxicity: the contribution of RNA molecules |
|
2009 |
| Evaluation fo prion protein interaction with heparin reveals pH-dependent binding sites |
|
2009 |
| THE PECULIAR INTERACTION BETWEEN MAMMALIAN PRION PROTEIN AND RNA |
|
2009 |
| Tumor Suppressor p53 WT and R248Q Core Domain Aggregation at Low pH |
|
2009 |
| Prion protein interaction with heparin |
|
2009 |
| Evaluation of Prion Protein Interaction with Quinoline Derivatives: Therapeutic Implications |
|
2009 |
| Structural and Physiological Implications of Prion Protein Interaction with DNA |
|
2009 |
| CHARACTERIZATION OF THE PRP:RNA COMPLEX: STRUCTURAL INSIGHTS AND TOXICITY STUDIES |
|
2008 |
| INVESTIGATION OF THE EFFECT OF HEPARIN ON PRION PROTEIN STRUCTURE |
|
2008 |
| BIOPHYSICAL STUDY AND SAXS-DERIVED LOW RESOLUTION MODEL OF PRION PROTEIN (PRP) COMPLEXED WITH THE CO-CHAPERONE HOP/STI-1 |
|
2008 |
| CHARACTERIZATION OF WILD-TYPE P53 AND MUTANT R248Q INTERMEDIATE STATES |
|
2007 |
| PrP:RNA INTERACTION GENERATES TOXIC SPECIES |
|
2007 |
| EVALUATION OF PRION PROTEIN INTERACTION WITH DNA: CALORIMETRIC ANALYSES AND CELLULAR TOXICITY ASSAYS |
|
2007 |
| DISSECTION OF PRION PROTEIN AND HEPARIN INTERACTION SITES |
|
2007 |
| Structural Basis for Nucleic Acid Binding to the Prion Protein |
|
2006 |
| Volume and energy folding landscape of prion protein revealed by pressure and calorimetry |
|
2006 |
| RNA binding acivity of the n-terminal domain of prion protein |
|
2006 |
| RNA binding activity of prion protein and toxicity of PrP-RNA aggregates |
|
2006 |
| Characterization of the Molten Globule State of a p53 Oncogenic Mutant |
|
2006 |
| The amino-terminal PrP domain is crucial to modulate prion misfolding and aggregation |
|
2005 |
| Structural Basis for Nucleic Acid Binding and Conformational Conversion of Prion Protein |
|
2005 |
| Modulation of Prion Protein Oligomerization, Aggregation and beta-sheet Conversion by 4,4'-dianilino-1,1'-binaphthyl-5,5'-sulfonate (bis-ANS) |
|
2004 |
| Specificity of Prion Protein Structure-Stability Relationship Probed by Lead Compounds and Thermodynamic Variables |
|
2004 |
| Effects of hydration and binding of nucleic acids and hydrophobic compounds on prion folding and beta-sheet conversion |
|
2004 |
| Hydration and packing effects on prion folding and beta-sheet conversion: High-pressure spectroscopy and pressure perturbation calorimetry studies |
|
2004 |
| Modulation of Hamster Prion Domains Aggregation by Naphthalene and Acridine Derivatives |
|
2003 |
| On the Reversibility of Prion Protein Aggregation |
|
2003 |
| Investigating the Stability of recPrP23-231 and recPrP(del 32-121) Against Pressure and Denaturing Agents |
|
2003 |
| Investigating the Stability of recPrP23-231 and recPrP(del 32-121) Against Pressure and Denaturing Agents |
|
2003 |
| DNA Converts Cellular Prion Protein into the Beta-sheet Conformation and Inhibits Prion Peptide Aggregation |
|
2002 |
| DNA Converts Cellular Prion Protein into the Beta-sheet Conformation and Inhibits Prion Peptide Aggregation |
|
2002 |
| DNA Converts Cellular Prion Protein into the Beta-sheet Conformation and Inhibits Prion Peptide Aggregation |
|
2002 |
| On the contributions of DNA binding on recombinant murine cellularPrP(23-231) stability |
|
2002 |
| Interaction of prion peptide and prion cellular protein with a hydrophobic probe and with nucleic acid |
|
2001 |
| Interaction of prion peptide and prion cellular protein with a hydrophobic probe and with nucleic acid |
|
2001 |
| ?Inhibition of the Prion Peptide (PrP 109-149) Aggregation by a |
|
2001 |
| ?Inhibition of the prion peptide PrP (109-149) aggregation by a hydrophobic compound |
|
2000 |
| Inhibition of Prion Peptides PrP (109-141) and PrP (109-149) Aggregation by a Hydrophobic Compound |
|
2000 |
| Study of the Effects of High Hydrostatic Pressure on the Simian Rotavirus SA11 Shell |
|
1999 |
| Nitric Oxide Production By Murine Spleen Cells After In Vivo Stimulation With Rotavirus Inactivated By High Pressure |
|
1998 |
| Nitric Oxide Production By Murine Spleen Cells After In Vivo Stimulation With Rotavirus Inactivated By High Hydrostatic Pressure |
|
1998 |
| High Pressure Inactivation of Simian Rotavirus: Evaluation of Nitric Oxide Production by Murine Spleen Cells |
|
1998 |
| Fluorescence Spectroscopy Properties of Rotavirus Subjected to High |
|
1997 |
| Studies of Brain Miosin V (BM V) Structure by Hydrostatic Pressure |
|
1995 |
